FDA Inspection
Kunming Pharmaceuticals IncKunming Pharmaceuticals Inc – FDA Inspection, Feb 23, 2017
Record Details
This FDA Inspection record concerns Kunming Pharmaceuticals Inc, with an inspection on February 23, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5a9dead4-f2f6-48d6-aaba-ddcd77af9e14
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1003819
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Kunming Pharmaceuticals Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 26, 2008 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kunming Pharmaceuticals Inc
- FDA Inspection 552602 - 2008-11-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.